British Journal of Radiology最新文献

{"title":"A Novel Approach to Differentiate Prostate Cancer from Prostatitis in the Peripheral Zone.","authors":"Chun-Lei He, Ting Yang, Meng-Ni Zhang, Jin Yao, Ling Yang","doi":"10.1093/bjr/tqaf186","DOIUrl":"https://doi.org/10.1093/bjr/tqaf186","url":null,"abstract":"<p><strong>Objectives: </strong>To analyze the different imaging manifestations of prostatitis and prostate cancer (PCa), and propose systematic differentiation and validate its diagnostic performance.</p><p><strong>Methods: </strong>Men with histologically proven prostatitis or PCa who had pretreatment multiparametric MRI (mpMRI) and lesions in the PZ were retrospectively identified from January 2018 to May 2022. The images were evaluated by two experienced radiologists, and key imaging features for differential diagnosis were summarized and analyzed via univariable and multivariable logistic regression. The best differentiating model was generated via refining the original PI-RADS standard (rPI-RADS). Two inexperienced radiologists reevaluated the images according to the PI-RADS and rPI-RADS criteria, then compared.</p><p><strong>Results: </strong>A total of 315 patients were enrolled in this study, including 181 patients with clinically significant PCa (67.3 ± 7.7 years) and 134 patients with prostatitis (64.8 ± 9.6 years). The differentiated model was based on diffuse distribution, wedge shape, T1 iso-hyperintensity, rim enhancement, and delayed periprostatic enhancement, thus forming the rPI-RADS standard according to these features. Paired comparison study showed that 22 out of 121 (18.2%, P < 0.001) inflammatory lesions were corrected from PI-RADS category 4-5 to rPI-RADS category 2, and 20 out of 121 (16.5%, P < 0.001) were corrected from PI-RADS category 4-5 to rPI-RADS category 1-3 by two inexperienced radiologists.</p><p><strong>Conclusion: </strong>The supplementary descriptions of wedge-shaped and diffuse distributed lesions were helpful for inexperienced radiologists. The refined principle of score reduction may reduce false-positive PI-RADS scores for prostatitis.</p><p><strong>Advances in knowledge: </strong>A systematic differentiation of prostate cancer from prostatitis was proposed, and validated by inexperienced radiologists.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144943804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intravasation is not only a complication but also a novel radiological finding for tubal pathologies in hysterosalpingography.","authors":"Cemil Gürses, Koray Kaya Kılıç, Alpaslan Yavuz, İclal Erdem Toslak, Ender Uysal, Berkan Sayal, Dilek Yapar","doi":"10.1093/bjr/tqaf199","DOIUrl":"10.1093/bjr/tqaf199","url":null,"abstract":"<p><strong>Objectives: </strong>Hysterosalpingography (HSG) remains the first-line imaging technique for assessing fallopian tube conditions due to its accessibility, cost-effectiveness, and high diagnostic accuracy. Intravasation, the leakage of contrast media into myometrial or vascular structures during HSG, has been documented as a complication.This study aimed to determine the prevalence of intravasation, explore the relationship between intravasation and tubal occlusion, and assess the applicability of grading intravasation.</p><p><strong>Methods: </strong>A retrospective analysis of 3,032 HSG examinations performed between January 2021 and May 2024 was conducted. Intravasation, tubal occlusion, and related findings were recorded using standard X-ray equipment and categorised prospectively. Statistical analysis included logistic regression to identify predictors of tubal occlusion and inter-observer agreement using Fleiss Kappa. Diagnostic metrics for intravasation as a radiological marker of tubal occlusion were calculated.</p><p><strong>Results: </strong>Intravasation was observed in 2.6% of cases. Among cases with tubal occlusion, 16.4% exhibited intravasation. The sensitivity, specificity, positive predictive value, and negative predictive value of intravasation for detecting tubal occlusion were 14.5%, 99.8%, 92.3%, and 85.6%, respectively. Adjusted odds ratios indicated that intravasation increased the likelihood of tubal occlusion approximately 55-fold. Inter-observer agreement for intravasation detection was almost perfect (Kappa = 0.97). Limitations included the absence of oil-based contrast and a pressure manometer during contrast infusion.</p><p><strong>Conclusion: </strong>Intravasation, traditionally viewed as a complication, emerges as a significant radiological indicator of tubal occlusion. Incorporating intravasation characteristics, such as initiation time, into grading systems may enhance diagnostic accuracy. Further refinement of classification systems and broader clinical validation are recommended.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144882235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"First-in-India Experience with 90Y-BhabhaSphere: An Indigenous 90Y-TheraSphere Biosimilar for Transarterial radioembolization of Hepatic Malignancies.","authors":"Ashish Kumar Jha, Ameya Puranik, Kunal Bharat Gala, K V Vimalnath, A Rajeswari, Sharad P Lohar, Aaditya Shah, Amala Mathai, Bikash K Tiwary, Nitin Sudhakar Shetye, Anupam Mathur, Usha Pandey, Sudipta Chakraborty, Nilendu Purandare, Suyash Kulkarni, Venkatesh Rangarajan","doi":"10.1093/bjr/tqaf197","DOIUrl":"https://doi.org/10.1093/bjr/tqaf197","url":null,"abstract":"<p><strong>Objective: </strong>Primary and secondary hepatic malignancies are a significant cause of cancer-related mortality worldwide. Radioembolization with yttrium-90 (90Y) microspheres has emerged as a promising treatment option for unresectable hepatic tumors. However, the high cost of commercially available Y-90 microspheres, such as 90Y-TheraSphere or 90Y-SirSphere, limits their accessibility in developing countries. We present the first Indian clinical experience of indigenously developed [90Y] Yttria Alumino Silicate glass microspheres, known as \"90Y-BhabhaSphere,\" for radioembolization of hepatic malignancies.</p><p><strong>Methods: </strong>\"90Y-BhabhaSphere\" formulation developed at XXXXXX XXXXXX XXXXXXXX XXXXXX (XXXX), XXXXX, was used to treat a small cohort of five patients with unresectable hepatic malignancies. The 90Y-BhabhaSphere delivery system was developed through a rigorous process and in vitro tested using a microcatheter connection to simulate the TARE procedure. Feasibility, safety, delivery efficiency and preliminary efficacy of treatment using 90Y-BhabhaSphere were assessed.</p><p><strong>Results: </strong>Our initial clinical experience with 90Y-BhabhaSphere demonstrates its safety and feasibility in treating hepatic malignancies. 90Y-BhabhaSphere demonstrated excellent delivery efficiency, reaching 99% in vitro (dummy run) and 97% in vivo (clinical delivery) 90Y-BhabhaSphere was successfully administered to four patients, whereas in one patient the delivery had to be terminated due to a leakage in the delivery system. The treatment was well-tolerated, with minimal adverse effects. Preliminary efficacy analysis shows promising results, with a significant reduction in tumor size and improvement in liver function.</p><p><strong>Conclusion: </strong>90Y-BhabhaSphere offers a cost-effective alternative to commercially available 90Y-microspheres. Our initial clinical experience demonstrates its safety, feasibility, and preliminary efficacy in treating hepatic malignancies. Large clinical trials need to be conducted to establish the long-term efficacy and safety of 90Y-BhabhaSphere.</p><p><strong>Advances in knowledge: </strong>This study highlights a key advantage of 90Y-BhabhaSphere: its significantly higher specific activity (approximately 6000 Bq/sphere) compared to commercially available 90Y-TheraSphere (2700 Bq/sphere). This suggests a potential for delivering higher tumor doses whileminimizing radiation exposure to healthy liver tissue, thereby reducing the risk of radiation-induced liver damage.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144871596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Early Detection of Cardiovascular Disease in Chest Population Screening: Challenges for a Rapidly Emerging Cardiac CT Application.","authors":"Anna N H Walstra, Jan Willem C Gratama, Marjolein A Heuvelmans, Matthijs Oudkerk","doi":"10.1093/bjr/tqaf195","DOIUrl":"https://doi.org/10.1093/bjr/tqaf195","url":null,"abstract":"<p><p>While lung cancer screening (LCS) reduces lung cancer-related mortality in high-risk individuals, cardiovascular disease (CVD) remains a leading cause of death due to shared risk factors such as smoking and age. Coronary artery calcium (CAC) assessment offers an opportunity for concurrent cardiovascular screening, with higher CAC scores indicating increased CVD risk and mortality. Despite guidelines recommending CAC-scoring on all non-contrast chest CT scans, a lack of standardization leads to underreporting and missed opportunities for preventive care. Routine CAC-scoring in LCS can enable personalized CVD management and reduce unnecessary treatments. However, challenges persist in achieving adequate diagnostic quality with one combined image acquisition for both lung and cardiovascular assessment. Advancements in CT technology have improved CAC quantification on low-dose CT scans. Electron-beam tomography, valued for superior temporal resolution, was replaced by multi-detector CT for better spatial resolution and general usability. Dual-source CT further improved temporal resolution and reduced motion artifacts, making non-gated CT protocols for CAC-assessment possible. Additionally, artificial intelligence-based CAC quantification can reduce the added workload of cardiovascular screening within LCS programs. This review explores recent advancements in cardiac CT technologies that address prior challenges in opportunistic CVD screening and considers key factors for integrating CVD screening into LCS programs, aiming for high-quality standardization in CAC reporting.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144871595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Accessory Hepatic Vein Recanalization: A Viable Approach in Hepatic Vein Outflow Tract Obstruction.","authors":"Yashwant Patidar, Vasav Tyagi, Navojit Chatterjee, Rajeev Ranjan, Amar Mukund, Manoj Kumar Sharma, Shiv Kumar Sarin","doi":"10.1093/bjr/tqaf198","DOIUrl":"https://doi.org/10.1093/bjr/tqaf198","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the mid and long term outcome of recanalization of accessory hepatic vein secondary to hepatic venous outflow obstruction and to compare the mid and long term outcome and technical efficacy and safety of accessory hepatic vein recanalization with native hepatic vein recanalization in HVOTO patients.</p><p><strong>Methods: </strong>This retrospective observational study, conducted at a single centre, evaluated the mid- and long-term outcomes of AHV recanalization compared to native HV recanalization in 170 HVOTO patients treated between January 2013 and October 2020.</p><p><strong>Results: </strong>Patients were divided into two groups based on the type of recanalization performed: AHV (n = 26) and native HV (n = 144). Technical success was achieved in 100% of AHV cases and 95.8% of native HV cases. The primary patency rates at 1, 3, and 5 years were 95.9%, 92.3%, and 76.9% for AHV and 96.5%, 93%, and 79.1% for native HV, respectively. Significant improvements in liver stiffness, clinical symptoms, and hepatic function were observed post-intervention in both groups, with no significant differences in outcomes. Transplant-free survival rates at 1, 3, and 5 years were also comparable between groups.</p><p><strong>Conclusion: </strong>This study demonstrates that AHV recanalization is a safe and effective alternative to native HV recanalization, providing comparable long-term outcomes.</p><p><strong>Advances in knowledge: </strong>It offers a promising option for HVOTO patients with dominant AHV and extensive intrahepatic collaterals, further supporting its integration into the stepwise management of HVOTO.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144871594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidental Findings Associated with Magnetic Resonance Imaging of the Hand and Wrist.","authors":"Megan A Beese, Prasant Gurung, Jack A Hall, Alexander Shuttleworth, Shuyi Zhen, Chiraag Karia, Grainne Bourke, Ryckie G Wade","doi":"10.1093/bjr/tqaf194","DOIUrl":"https://doi.org/10.1093/bjr/tqaf194","url":null,"abstract":"<p><strong>Objectives: </strong>To identify the prevalence of incidentalomas and incidental findings in symptomatic patients undergoing MRI of the hand or wrist.</p><p><strong>Methods: </strong>This retrospective cross-sectional study included all children and adults who completed MRI of the hand or wrist over a 14-year period in a single UK tertiary centre. An incidental finding was any abnormality (structural or signal-based), suspected injury or disease-process that was not already established or suspected. Incidentalomas were defined as incidental findings requiring further investigation or treatment. Marginal standardisation was used to explore relationships between prognostic factors and outcomes.</p><p><strong>Results: </strong>Overall, 490 out of 2138 (22.9%) scans contained one or more incidental anomalies and 67 (3.1%) had at least one incidentaloma. The risk of incidentalomas doubled (RR: 1.93, 95% CI: [1.01, 3.70]) when reported by a trainee and reviewed by a consultant compared to a consultant alone; increased by 12% (RR: 1.12, 95% CI: [0.98, 1.28]) per additional decade of life; and were less likely (RR: 0.34, 95% CI: [0.12, 0.94]) when contrast was used. 3 incidentalomas were found to be malignant (3.3%).</p><p><strong>Conclusions: </strong>The risk of incidentalomas and incidental findings in MRI of the hand and wrist is lower than solid organs. Our data may be used to inform patients about the risks of imaging and allow health services to plan the capacity and capability to deal with such events.</p><p><strong>Advances in knowledge: </strong>One in four hand or wrist MRIs yields an incidental finding and out of these, around one in seven required further action.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Screening mammography a decade post-tomosynthesis: Varied utilization of synthetic mammography across a large health system.","authors":"Xinhua Li, Catherine S Giess, Sona A Chikarmane, Madan M Rehani, Theodore A Marschall, Kai Yang, Bob Liu","doi":"10.1093/bjr/tqaf137","DOIUrl":"https://doi.org/10.1093/bjr/tqaf137","url":null,"abstract":"<p><strong>Objectives: </strong>Digital breast tomosynthesis (DBT) with two-dimensional acquisition (2D) was approved in 2011 for breast cancer screening in the U.S. To reduce radiation dose to breasts, synthetic mammography (SM) was developed and approved to replace 2D with combo DBT in 2013. This retrospective study of screening practices in a large, incompletely integrated health system, assesses extent of SM utilization, and examines its impact on average glandular dose (AGD).</p><p><strong>Methods: </strong>Consecutive screening exams on 61 mammography systems at nine hospitals from February 26 to March 12, 2023, were examined. Data collection included patient exams and radiation exposure. Comprehensive analysis included number of 2D acquisitions, three-dimensional (3D) views, breast thickness, and AGD. Comparative assessments were made across the health system cohort and individual hospitals. Statistical analysis was performed using the R statistical software (version 4.3.2).</p><p><strong>Results: </strong>This study included 6849 screening exams on 13,484 breasts (thickness, 5.96 ± 1.47 cm) that received 3D views (13482/13484, or 99.99%) and 2D acquisitions (9459/13484, or 70.15%). For average breast thickness (about 6 cm), mean AGD per breast was 0.29-5.32 mGy (2D only), 4-6.1 mGy (3D only), and 5.5-9.94 mGy (2D/3D). Three hospitals preferentially used SM (81.3-93.5% of breasts). For an average breast, the ratio of mean AGD(3D) without 2D acquisitions to mean AGD(3D + 2D) with 2D acquisitions was 0.589 (95% CI: 0.561-0.619), 0.625 (0.563-0.702), and 0.588 (0.508-0.696), respectively.</p><p><strong>Conclusions: </strong>Synthetic mammography reduces AGD. There is a need to review recurring screening mammographic exams and optimize patient doses by adopting synthetic mammography, where it meets the clinic's requirements.</p><p><strong>Advances in knowledge: </strong>Synthetic mammography reduces average glandular dose by 36.5%, but only three of nine hospitals within the same large health system have adopted this technology. Breast centers should consider reviewing their imaging protocols to optimize radiation doses for patients undergoing annual screening mammography with synthetic mammography.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An assessment of the average glandular dose of breast cone-beam CT in China based on clinical patients.","authors":"Ke Xue, Hui Xu, Bao-Rong Yue, Yan-Qiu Ding, Zhao-Xiang Ye","doi":"10.1093/bjr/tqaf193","DOIUrl":"https://doi.org/10.1093/bjr/tqaf193","url":null,"abstract":"<p><strong>Objectives: </strong>To quantify the non-compressed breast characteristics of females and the typical scanning parameters of breast cone-beam computed tomography (CBCT), and to provide a preliminary assessment of the average glandular dose (AGD) of breast CBCT in China.</p><p><strong>Methods: </strong>This study retrospectively analysed three-dimensional breast imaging data from 1,590 Chinese women who underwent non-enhanced breast CBCT scans in different regions between October 2020 and November 2023. Initially, a semi-automatic measurement tool integrated into the breast CBCT system was used to quantify the breast characteristics for each patient, including effective diameter at the chest-wall (Deff), chest-wall to nipple length (CNL), breast volume (BV), glandular volume (GV), and volumetric breast density (VBD). Then, the AGD for each patient was calculated using the dose conversion factor, combining breast characteristics and scanning parameters.</p><p><strong>Results: </strong>The overall median values of Deff, CNL, BV, GV, and VBD reflecting breast characteristics were 12.6 cm, 6.8 cm, 370.6 cm3, 46.7 cm3, and 14.4%, respectively. The tube voltage was fixed at 49 kVp, and the typical tube current was 50 mA. Under the typical scanning parameters, the AGD ranged from 3.9 to 5.1 mGy (median 4.9 mGy).</p><p><strong>Conclusions: </strong>The typical AGD for non-enhanced breast CBCT scanning is approximately 1.81 times higher than the cumulative radiation dose from two digital mammography (DM) views in China.</p><p><strong>Advances in knowledge: </strong>This study assessed the AGD of patients undergoing breast CBCT examination based on a large amount of clinical data, providing valuable guidance to clinicians in choosing appropriate breast imaging modalities.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Setting the Research Priorities for Pregnancy Scanning: A Nationally co-produced vision with expectant women, the public and healthcare professionals.","authors":"Jacqueline Matthew, Sharon Watty, Julie Nihouarn Sigurdardottir, Christina Malamateniou, Emily Skelton, Zenab Barry, Mary Rutherford, Sergio A Silverio, Lisa Story","doi":"10.1093/bjr/tqaf192","DOIUrl":"https://doi.org/10.1093/bjr/tqaf192","url":null,"abstract":"<p><strong>Objectives: </strong>Despite sonography studies being integral to routine high quality antenatal care, clinical research in this field is less commonly initiated or led by sonography professionals. It is also unclear what the research priorities are for service users within the UK's sonography screening and diagnostic pathway.</p><p><strong>Methods: </strong>Here, we present a national priority setting partnership project, which included two surveys which were co-produced with the oversight of a stakeholder PSP group comprising service users and healthcare professionals, n = 12.</p><p><strong>Results: </strong>From the surveys, there were 348 individual responses and 616 validated research questions/uncertainties submitted. The top-ranked 26 indicative questions were discussed at a final joint stakeholder meeting (n = 17) and the top 10 research priorities for pregnancy scanning research were voted for and agreed by consensus. These fell into six main themes: 1. Maternal and parental experience; 2. Emerging technology; 3, Screening, prediction, and diagnosis, 4, Role of pregnancy MRI, 5, Continued professional development, training and education; and, 6. Service delivery and workforce.</p><p><strong>Conclusions: </strong>We envisage this PSP will support teams of researchers and clinicians with important and achievable targets to move the field of pregnancy scanning forward.</p><p><strong>Advances in knowledge: </strong>This is the first co-produced antenatal scanning priority setting partnership highlighting real world issues and lines of enquiry as proposed by service users and health care professionals.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144783564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Research Article.","authors":"Javeria Khan, Muqadas Qureshi, Arif Rasheed, Syed Muhammad Yousuf Farooq","doi":"10.1093/bjr/tqaf190","DOIUrl":"https://doi.org/10.1093/bjr/tqaf190","url":null,"abstract":"<p><strong>Objective: </strong>To compare transabdominal and transvaginal ultrasound for the assessment of cervical length in the third trimester of pregnancy.</p><p><strong>Methods: </strong>In this cross-sectional analytical study, a total of 500 pregnant women were screened, out of which 223 women, aged 18 to 45 years, with a gestational age of 26-30 weeks in the third trimester, were enrolled. Prior to participation, all subjects provided written informed consent and were made aware of the potential risks and benefits associated with the procedure. Clinical and demographic data, including risk factors and medical history, were collected using a pre-designed data collection form. Gestational age was determined based on the last menstrual period.</p><p><strong>Results: </strong>TAS and TVS measurements of cervical length were made on 229 pregnancies of 26-40 weeks gestation. Out of 223 patients, there were 102 females had lower abdominal pain there were 100 females had bleeding and 126 females had cephalic position and breech 97. at 223 women were initially enrolled in the study. Paired TAS and TVS measurements were obtained in 123 (51.3%) women. The mean TVS CL was 35.2 ± 6.8 mm, and the mean TAS CL was 34.7 ± 6.5 mm. Significant differences were identified between the mean CL measurements of the two techniques (P < 0.05).</p><p><strong>Conclusion: </strong>both TAS and TVS are valuable tools for cervical length assessment, TVS should be considered the gold standard for more accurate and reliable measurements, especially in clinical settings where precise monitoring of cervical length is necessary.</p><p><strong>Advances in knowledge: </strong>By providing a novel comparison between transvaginal and transabdominal ultrasonography for the assessment of cervical length in the third trimester, this study advances our understanding of how to optimize measuring methods for the reduction of preterm birth risks.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144774713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}